[Registration Closed] (Webinar) HGPI-Supported: Youth Engagement Seminar on Antimicrobial Resistance – lessons from global perspective by Dame Sally Davies, UK Special Envoy on AMR – (February 27, 2023)
date : 2/21/2023
Tags: AMR
![[Registration Closed] (Webinar) HGPI-Supported: Youth Engagement Seminar on Antimicrobial Resistance – lessons from global perspective by Dame Sally Davies, UK Special Envoy on AMR – (February 27, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-20230227.png)
Health and Global Policy Institute (HGPI) is supporting youth Engagement Seminar on Antimicrobial Resistance – lessons from global perspective by Dame Sally Davies, UK Special Envoy on AMR – which is scheduled to be held on Monday, 27 February 2023 and co-hosted by British Embassy Tokyo, City of Himeji and Himeji Red Cross Hospital.
Antimicrobial resistance (AMR) has been increasing both domestically and internationally, and the annual number of deaths due to AMR infections is projected to increase to about 10 million people globally by 2050. This seminar aims to provide youth researchers and medical/pharmaceutical university students an opportunity to engage and learn about issues of AMR from Dame Sally Davies, Special Envoy for AMR in the UK.
*In-person participation at the venue is by invitation only.
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
- [Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (AMR Alliance Japan, December 22, 2021)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] The Future of Dementia Policy 2022: Deepening Dementia Policies Centered on People Living with Dementia and their Families to Lead Global Society (July 13, 2022)
- [Announcement] HGPI Declares the Ministry of the Environment-led ‘Deco-Katsu Declaration’ and Participation in the ‘Deco-Katsu’ Supporters (October 16, 2023)
Featured Posts
-
2023-10-31
[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
-
2023-11-27
[Registration Open] (Webinar) HGPI Cooperation with Lancet Countdown 2023 Japan Presentation “Climate Change as a Children’s Health Issue: The Latest Lancet Report Sounds the Alarm for Health Commitments” (December 14, 2023)
-
2023-11-28
[Event Report] The 1st Advisory Board Meeting for Patient and Public Involvement (PPI) Support Project “Necessary Steps for Promoting PPI in Policy Making” (October 3, 2023)
-
2023-11-29
[Policy Recommendations] Coming Together to Protect and Foster: Promoting Innovative and Sustainable Planetary Health in the Asia-Pacific Region to Build Resilient Health Systems (November 29, 2023)
-
2023-11-30
[Announcement] HGPI Endorsed “For the Health of People and Planet: Priorities for a Healthy COP28” (November 30, 2023)